- Home
- CHX vs BPMC Comparison
CHX vs BPMC Comparison
Compare CHX & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHX
- BPMC
- Stock Information
- Founded
- CHX 1882
- BPMC 2008
- Country
- CHX United States
- BPMC United States
- Employees
- CHX N/A
- BPMC N/A
- Industry
- CHX Industrial Machinery/Components
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- CHX Industrials
- BPMC Health Care
- Exchange
- CHX Nasdaq
- BPMC Nasdaq
- Market Cap
- CHX 5.2B
- BPMC 5.9B
- IPO Year
- CHX N/A
- BPMC 2015
- Fundamental
- Price
- CHX $25.79
- BPMC $90.14
- Analyst Decision
- CHX Buy
- BPMC Buy
- Analyst Count
- CHX 4
- BPMC 20
- Target Price
- CHX $39.00
- BPMC $120.79
- AVG Volume (30 Days)
- CHX 1.9M
- BPMC 667.8K
- Earning Date
- CHX 02-03-2025
- BPMC 02-13-2025
- Dividend Yield
- CHX 1.47%
- BPMC N/A
- EPS Growth
- CHX 7.15
- BPMC N/A
- EPS
- CHX 1.62
- BPMC N/A
- Revenue
- CHX $3,665,501,000.00
- BPMC $434,415,000.00
- Revenue This Year
- CHX N/A
- BPMC $108.09
- Revenue Next Year
- CHX $3.98
- BPMC $39.34
- P/E Ratio
- CHX $15.92
- BPMC N/A
- Revenue Growth
- CHX N/A
- BPMC 100.93
- 52 Week Low
- CHX $25.46
- BPMC $72.24
- 52 Week High
- CHX $39.95
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- CHX 22.21
- BPMC 42.11
- Support Level
- CHX $28.66
- BPMC $86.02
- Resistance Level
- CHX $29.69
- BPMC $98.41
- Average True Range (ATR)
- CHX 0.78
- BPMC 3.28
- MACD
- CHX -0.43
- BPMC -0.76
- Stochastic Oscillator
- CHX 5.55
- BPMC 33.04
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.